Phase 3 Apact Trial Of Adjuvant Nab-Paclitaxel Plus Gemcitabine (Nab-P Plus Gem) Vs Gemcitabine (Gem) Alone In Patients With Resected Pancreatic Cancer (Pc): Updated 5-Year Overall Survival
ANNALS OF ONCOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要